Significance of initial clinical laboratory parameters as prognostic factors in patients with COVID 19

Abstract

Background/Aim. Coronavirus disease 2019 (COVID-19) is a predominantly respiratory disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The aim of this study was to determine whether there were parameters that could predict the development of a severe clinical picture and fatal outcomes in COVID-19 patients. Methods. The study involved 632 patients treated at the Clinic for Infectious Diseases, University Clinical Center Kragujevac, from June 2020 to February 2021. All patients were divided into two groups according to the need for oxygen therapy (Sat 02 < 94 %). Results. Our results showed that high body mass i ndex (BMI) was singled out as a risk factor for the development of a severe clinical picture (BMI, ORadjusted = 1.263; 95% CI = 1.117 ? 1.427; p < 0.001). Prothrombin time (ORadjusted = 1.170; 95% CI = 1.004 - 1.364; p = 0.045), as well as low albumin values (ORadjusted = 0.878; 95% CI = 0.804 - 0.958; p = 0.003), had a predictive signifi-cance for the development of a severe clinical picture. Fac-tors that were of predictive importance in patients with fatal outcomes were C-reactive protein (CRP) (ORadjusted = 1.010; 95% CI = 1.001 ? 1.019; p = 0.031), lactate dehydrogenase (LDH) (ORadjusted = 1.004; 95% CI = 1.001 ? 1.006; p = 0.002), and X-ray of the lungs (ORadjusted = 1.394; 95% CI = 1.170 ? 1.661; p < 0.001). Conclusion. The study showed that routine, clinical laboratory parameters can be important in the early detection of patients with a potentially severe clinical picture and fatal outcomes. In patients with a mild clinical picture, CRP, LDH, ferritin, and serum albumin levels may timely indicate disease progression. Monitoring these parameters is of essential importance for the timely clinical assessment of patients with COVID-19 and, thus, the prompt application of adequate therapeutic protocols in the treatment of these patients.